![](/img/cover-not-exists.png)
Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment
Cartron, G., Ohresser, M., Salles, G., Solal-Celigny, P., Colombat, P., Watier, H.Volume:
19
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdn163
Date:
August, 2008
File:
PDF, 74 KB
english, 2008